Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Merck
Express Scripts
Chubb
Citi
UBS
Federal Trade Commission
Mallinckrodt

Generated: May 27, 2018

DrugPatentWatch Database Preview

PROSTIN F2 ALPHA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Prostin F2 Alpha patents expire, and what generic alternatives are available?

Prostin F2 Alpha is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.
Drug patent expirations by year for PROSTIN F2 ALPHA
Medical Subject Heading (MeSH) Categories for PROSTIN F2 ALPHA
Synonyms for PROSTIN F2 ALPHA
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt
(E,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)@component of Prostin F2 Alpha, injectable
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oate (salt)
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
36300-07-9
38473-38-0
38562-01-5
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, tham
5-Heptenoic acid,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, THAM
51553-13-0
562D015
562P015
7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, tromethamine salt
7-[3, tromethamine salt
9?,11?,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic acid tris(hydroxymethyl)aminomethane salt
AC1NR011
AK-72816
AKOS015920234
AN-110
AT-5102
B7617
BR-72816
C12786
C20H34O5.C4H11NO3
CC-27068
CHEBI:31502
CHEMBL1200896
CT6BBQ5A68
D01352
D04RGA
DB01160
Dinolytic
Dinoprost (tromethamine salt)
Dinoprost compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Dinoprost trometamol
Dinoprost trometamol, European Pharmacopoeia (EP) Reference Standard
dinoprost tromethamine
Dinoprost tromethamine (JAN/USP)
Dinoprost tromethamine [USAN:JAN]
Dinoprost Tromethamine Salt
Dinoprost tromethamine, United States Pharmacopeia (USP) Reference Standard
Dinoprost, trometamol salt
DR002945
EINECS 254-002-3
Ensaprost
Enzaprost F compd. with trisamine
glandin; tris buffer
HMS2230J05
HY-12956A
LP087295
LS-125841
Lutalyse
Lutalyse (Veterinary)
MFCD00077863
MLS000028821
MolPort-003-939-186
NSC 196515
NSC-196515
NSC196515
Opera_ID_1888
Panacelan F tromethamine salt
PGF2-alpha tham
PGF2-alpha tris salt
PGF2-alpha tromethamine
PGF2-alpha tromethamine salt
PGF2.alpha. THAM
PGF2alpha THAM
PGF2alpha tromethamine
PGF2ALPHA-THAM
PGF2alpha-Tris
Pronalgon F
Prosta-5, (5Z,9.alpha.,11.alpha.,13E,15S)-9,11,15-trihydroxy- compd. with (trimethylolamino)methane
Prosta-5, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-, compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-,compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prostaglandin F-2alpha tromethamine salt
Prostaglandin F(2)(alpha) tris salt
Prostaglandin F(sub 2a) tromethamine
Prostaglandin F2-alpha THAM
Prostaglandin F2-alpha THAM salt
Prostaglandin F2-alpha tromethamine
Prostaglandin F2?
Prostaglandin F2.alpha. THAM
Prostaglandin F2.alpha.,3-propanediol (1:1)
Prostaglandin F2|A
Prostaglandin F2a tris salt
Prostaglandin F2a tromethamine
Prostaglandin F2alpha (tromethamine salt)
Prostaglandin F2alpha tham
PROSTAGLANDIN F2ALPHA TRIS SALT
Prostaglandin F2alpha tris salt, >=99%, synthetic, powder
Prostaglandin F2alpha tris salt, synthetic, cell culture tested
prostaglandin F2alpha tromethamine
Prostalmon F
Prostamate
Prostin F2 alpha (TN)
Prostin F2 alpha,3-propanediol (1:1)
Protaglandin F2-alpha-tham salt
REGID_for_CID_5282415
RP17760
SCHEMBL203377
SMR000058792
SR-01000946463
SR-01000946463-1
THAM PGF2-alpha
Tromethamine prostaglandin F2-alpha
U 14585
U-14
U-14,583E
U-14583E
UNII-CT6BBQ5A68
WLN: L5TJ AQ B2U4VQ C1U1YQ5 DQ &Q1XZ1Q1Q
Zinoprost

US Patents and Regulatory Information for PROSTIN F2 ALPHA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for PROSTIN F2 ALPHA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
McKinsey
Boehringer Ingelheim
Queensland Health
QuintilesIMS
Accenture
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.